Abstract
This paper tries to analyze profitability performance of pharmaceutical companies listed in Dhaka stock exchange in Bangladesh. To achieve the objectives, data have been collected from secondary sources of listed pharmaceutical companies listed in Dhaka stock exchange for the period from 2000-01 to 2017-18. The collected data have been categorized, tabulated and analyzed by different profitability ratios and statistical tools like mean, standard deviation and coefficient of variation. The financial ratios includes gross profit margin, operating profit margin, and net profit margin, return on equity, return on assets. The results indicates that overall profitability of the industry is satisfactory but ambee, Ibn Sina, beximco and glaxo have enough scope to improve operational efficiency and pricing strategy, assets using to generate and retain profit for the shareholders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
